Summary
The binding affinity of sulphated insulin compared with unmodified, neutral insulin has been reported to be approximately four times lower in human and rat adipocytes but over twenty times lower in rat hepatocytes. In the present study the biological action of sulphated insulin was assesed in rat hepatocytes and human and rat adipocytes. To achieve half-maximal stimulation of fatty acid synthesis in rat hepatocytes about twenty one times higher concentrations of sulphated than neutral insulin were required (15.07±5.50 vs 0.71±0.34 nmol/l), this ratio being similar to the ratio of binding affinity in rat hepatocytes. In human adipocytes, half-maximal stimulation of initial rates of glucose uptake was observed at 11.6±5.1 vs 2.9±1.3 pmol/l for sulphated and neutral insulin respectively, and half-maximal inhibition of lipolysis at 31.0±13.5 vs 7.3+2.5 pmol/I respectively. These data are consistent with the four-fold lower binding affinity of sulphated insulin to human adipocytes. However, in rat adipocytes the biological potency of sulphated insulin was found to be much lower than anticipated from the binding data, half-maximal stimulation of initial rates of glucose uptake being observed at 757±299 vs 35±13 pmol/l respectively and half-maximal inhibition of lipolysis at 35.9±12.1 vs 1.5±0.5 pmol/l respectively. Thus, in rat adipocytes, approximately 22 times the concentration of sulphated insulin was required to achieve equivalent biological effect. A discrepancy between binding affinity and biological action with respect to sulphated insulin was identified in rat adipocytes but not human adipocytes nor rat hepatocytes suggesting differences in the binding-action linkage in these cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albisser AM, Lougheed WD, Chow JC, Tung AK: A modified insulin for pumps. Diabetes 31 (Suppl. 2):67A, 1982.
Moloney PJ, Aprile MA, Wilson S: Sulphated insulin for treatment of insulin-resistant diabetics. J New Drugs 4:258–263, 1964.
Pongor S, Brownlee M, Cerami A: Preparation of highpotency, non-aggregating insulins using a novel sulphation procedure. Diabetes 32:1087–1091, 1983.
Thomas JH: Electrophoresis of 35S-sulphated insulin: immunological and biological properties of the H.O. isolated electrophoretic components. Horm Metab Res 3:207–212, 1971.
Lougheed WD, Woulfe-Flanagan H, Clement JR, Albisser AM: Insulin aggregation in artificial delivery systems. Diabetologia 19:1–9, 1980.
Chen RF: Removal of fatty acids from serum albumin by charcoal treatment. J Biol Chem 242:173–181, 1967.
Hanson RW, Ballard FJ: Citrate, pyruvate and lactate contaminants of commercial serum albumin. J Lipid Res 9:667–668, 1968.
Seglen PO: Preparation of isolated rat liver cells. Methods Cell Biol 13:29–83, 1976.
Krebs HA, Henseleit K: Untersuchungen ueber die Harnstoffbildung im Tierkorper. Hoppe-Seyler's Z Physiol Chem 210:33–66, 1932.
Jungas RL: Fatty acid synthesis in adipose tissue incubated in tritiated water. Biochemistry 7:3708–3717, 1968.
Agius L, Vaartjes WJ: The effects of orthovanadate on fatty acid synthesis in isolated rat hepatocytes. Biochem J 202:791–794, 1982.
Stansbie D, Brownsey RW, Cretlaz M, Denton RM: Acute effects in vivo of anti-insulin serum on rates of fatty acid synthesis and activities of acetyl-coenzyme carboxylase and pyruvate dehydrogenase in liver and epididymal adipose tissue of fed rats. Biochem J 160:413–416, 1976.
Pedersen O, Gliemann J: Hexose transport in human adipocytes: Factors influencing the response to insulin and kinetics of methylglucose and glucose transport. Diabetologia 20:630–635, 1981.
Zeuzem S, Taylor R: Assessment of human adipocyte glucose uptake using the physiological substrate D-glucose. Scand J Clin Lab Invest 1985. In Press.
Pedersen O, Hjollund E, Lindskov HO: Insulin binding and action on fat cells from young healthy females and males. Am J Physiol 243:E158-E167, 1982.
Thomas SHL, Wisher MH, Brandenburg D, Sonksen PH: Insulin action on adipocytes: Evidence that the anti-lipolytic and lipogenic effects of insulin are mediated by the same receptor. Biochem J 184:355–360, 1979.
Eggstein M: Eine neue Bestimmung der Neutralfette im Blutserum und Gewebe. Klin Wschr 44:267–273, 1966.
Pedersen O, Hjollund E, Sorensen NS: Insulin receptor binding and insulin action in human fat cells: effects of obesity and fasting. Metabolism 31:884–895, 1982.
Pilch PF, Czech MP: The subunit structure of the high affinity insulin receptor. Evidence for a disulfide-linked receptor complex in fat cells and liver plasma membranes. J Biol Chem 255:1722–1731, 1980.
Schweitzer JB, Smith RM, Jarett L: Differences in the organizational structure of the insulin receptor on rat adipocyte and liver plasma membranes. The role of disulfide bonds. Proc Natl Acad Sci USA 77:4692–4696, 1980.
Jarett L, Smith RM: Ultrastructural localization of insulin receptors on adipocytes. Proc Natl Acad Sci USA 72:3526–3530, 1975.
Jarett L, Smith RM: The natural occurrence of insulin receptors in groups on adipocyte plasma membranes as demonstrated with monomeric ferritin-insulin. J Supramol Struct 6:45–59, 1977.
Jarett L, Smith RM: Effects of Cytochalasin B and D on groups of insulin receptors and insulin action in rat adipocytes. J Clin Invest 63:571–579, 1979.
Schechter Y, Chang KJ, Jacobs S, Cuatrecasas P: Modulation of binding and bioactivity of insulin by anti-insulin antibody: relation to possible role of receptor self-aggregation in hormone action. Proc Natl Acad Sci USA 76:2720–2724, 1976.
Zeuzem S, Taylor R, Agius L, Albisser AM, Alberti KGMM: Differential binding of sulphated insulin to adipocytes and hepatocytes. Diabetologia 27:441–446, 1984.
Gammeltoft S, Kristensen LO, Sestoft L: Insulin receptors in isolated rat hepatocytes: reassessment of binding properties and observations on the inactivation of insulin at 37 °C. J Biol Chem 253:8406–8413, 1978.
Schuttler A, Brandenburg D: Preparation and properties of covalently linked insulin dimers. Hoppe-Seyler's Z Physiol Chem 363:317–330, 1982.
Podlecki DA, Frank BH, Kao M, Hirikoshi H, Freidenberg G, Marshall S, Ciaraldi T, Olefsky JM: Characterisation of the receptor binding properties of monoiodoinsulin isomers and the identification of different insulin receptor specificities in hepatic and extrahepatic tissues. Diabetes 32:697–704, 1983.
Frank BH, Peavy DE, Hooker CS, Duckworth WC: Receptor binding properties of monoiodo insulin isomers purified by high performance liquid chromatography. Diabetes32:705–711, 1983.
Olefsky JM, Johnson J, Liu F, Edwards P, Baur S: Comparison of 125I-insulin binding and degradation to isolated rat hepatocytes and liver membranes. Diabetes 24:801–810, 1975.
Emdin SO, Sonne O, Gliemann J: Hagfish insulin: The discrepancy between binding affinity and biological activity. Diabetes 29:301–303, 1980.
Horuk R, Blundell TL, Lazarus NR, Neville RWJ, Stone D, Wollmer A: A monomeric insulin from the porcupine (Hystrix cristata), an Old World hystricomorph. Nature 286:823–824, 1980.
Rosen P, Simon M, Reinauer H, Friesen HJ, Diaconescu C, Brandenburg D:Binding of insulin to bovine liver plasma membrane. Use of insulin analogues modified at the Al residue. Biochem J 186:945–952, 1980.
Geiger R, Obermeier R, Teetz V, Uhmann R, Summ HD, Neubauer H, Geisen K, Regitz G: In: Brandenburg D. Wollmer A (eds) Insulin: Chemistry, Structure and Function of Insulin and Related Hormones 1980, pp. 409–415.
Burke GT, Chanley JD, Okada Y, Cosmatos A, Frederigos N, Katsoyannis GP: Divergence of the in vitro biological activity and receptor binding affinity of a synthetic insulin analogue, [21-asparaginamide-A] insulin. Biochemistry 19:4547–4556, 1980.
Schlessinger J, Shechter Y, Cuatrecasas P, Pastan I: Direct visualisation of binding, aggregation and internalisation of insulin and epidermal growth factor on fibroblastic cells. Proc Natl Acad Sci USA 75:2659–2663, 1978.
Jarett L, Smith RM: Electron microscopic demonstration of insulin receptors on adipocyte plasma membranes using a ferritin-insulin conjugate. J Biol Chem 249:7024–7031, 1974.
Kahn CR, Baird KL, Jarrett DB, Flier JS: Direct demonstration that receptor crosslinking or aggregation is important in insulin action. Proc Natl Acad Sci USA 75:4209–4213, 1978.
Jeffrey PD: The interactions of insulin with its receptor: crosslinking via insulin association as the source of receptor clustering. Diabetologia 23:381–385, 1982.
Saunders DJ: A new interpretation of structure-function relationships in insulin-receptor interactions. Diabetologia 23:386–390, 1982.
Reitz HC, Ferrel RE, Fraenkel-Conrat H, Olcott HS: Action of sulfating agents on proteins and model substances. I. Concentrated Sulfuric acid. J Amer Chem Soc 68:1024–1034, 1946.
Pullen RA, Lindsay DG, Wood SP, Tickle IJ, Blundell TL, Wollmer A, Krail G, Brandenburg D, Zahn H, Gliemann J, Gammeltoft S: Receptor-binding region of insulin. Nature 259:369–373, 1976.
Emdin SO, Gammeltoft S, Gliemann J: Degradation, receptor binding affinity and potency of insulin from the Atlantic Hagfish (Myxine glutinosa) determined in isolated rat fat cells. J Biol Chem252:602–608, 1977.
DeMeyts P, Van Obberghen E, Roth J, Wollmer A, Brandenburg D: Mapping of the residues responsible for the negative cooperativity of the receptor-binding region of insulin. Nature273:504–509, 1978.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zeuzem, S., Taylor, R., Agius, L. et al. Biological effects of sulphated insulin in adipocytes and hepatocytes. Mol Cell Biochem 68, 161–168 (1985). https://doi.org/10.1007/BF00219380
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00219380